Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has entered a key licensing agreement with Telesis Bio Inc. to integrate the ...

A new antivenom relies on antibodies from the blood of Tim Friede, who immunized himself against snakebites by injecting increasing doses of venom into his body.

Another factor that may be contributing to the decline in publishing by industry medicinal chemists is the fact that ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Initial experimental results showed that the tool helped modify the target gene in more than 90% of Escherichia coli colonies ...

Conference: LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar Date/Time: Thursday, May 29 th at 2:40 PM ET Presenter: Timothy Lu, M.D., Ph.D. Co-Founder and Chief Executive ...

These scents, now bottled by a new biotech perfume brand called Future Society, never touched the noses of anyone alive today ...

The Phase 1/2 clinical trial ( NCT06810544) is evaluating the safety, pharmacokinetics, pharmacodynamics and antitumor activity of TNG456 as a monotherapy and in combination with abemaciclib. We are ...

BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...